Search hospitals > Texas > Conroe
MD Anderson in The Woodlands
Claim this profileConroe, Texas 77384
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Recurrence
97 reported clinical trials
49 medical researchers
Summary
MD Anderson in The Woodlands is a medical facility located in Conroe, Texas. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. MD Anderson in The Woodlands is involved with conducting 97 clinical trials across 154 conditions. There are 49 research doctors associated with this hospital, such as Funda Meric-Bernstam, MD, Aung Naing, MD, Shannon Westin, MD, and Naoto T. Ueno.Area of expertise
1Cancer
Global LeaderStage IV
Stage II
Stage III
2Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
Top PIs
Funda Meric-Bernstam, MDM D Anderson Cancer Center4 years of reported clinical research
Expert in Solid Tumors
Expert in Cancer
30 reported clinical trials
90 drugs studied
Aung Naing, MDMD Anderson Cancer Center1 year of reported clinical research
Expert in Tumors
Expert in Solid Tumors
22 reported clinical trials
43 drugs studied
Shannon Westin, MDM D Anderson Cancer Center5 years of reported clinical research
Expert in Ovarian Cancer
Studies Endometrial Cancer
19 reported clinical trials
35 drugs studied
Naoto T. UenoM D Anderson Cancer Center7 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
13 reported clinical trials
26 drugs studied
Clinical Trials running at MD Anderson in The Woodlands
Breast Cancer
Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Esophageal Carcinoma
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Squamous Cell Carcinoma
Prostate Cancer
Anal Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at MD Anderson in The Woodlands?
MD Anderson in The Woodlands is a medical facility located in Conroe, Texas. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Recurrence and other specialties. MD Anderson in The Woodlands is involved with conducting 97 clinical trials across 154 conditions. There are 49 research doctors associated with this hospital, such as Funda Meric-Bernstam, MD, Aung Naing, MD, Shannon Westin, MD, and Naoto T. Ueno.